Charles Hauser, John Vann named to PMG Research Board of Directors

PMG Research names Charles Hauser, CEO of Piedmont Stone Center, and John Vann, Business Management Consultant with The Summit Company, to its Board of Directors.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
We are grateful for the participation of Mr. Hauser and Mr. Vann on our Board of Directors.

Winston-Salem, NC (PRWEB) August 07, 2014

PMG Research, Inc. announced today the election of its Board of Directors. Charles Hauser, CEO of Piedmont Stone Center, and John Vann, a business management consultant at The Summit Companies, will join Jennifer Byrne, Chairman of the Board and CEO of PMG Research, and Joel Lanik, Partner at Frontier Capital, as Directors on PMG Research Board.

PMG Research is a network of sites that provide clinical research services to pharmaceutical companies and CROs, with access to 1.7 million patient lives through its partnerships with large physician practices and integrated health systems. PMG Research is comprised of 10 hub site locations in the Southeastern United States and spans 53 physician practices.

“I am pleased to be a member of the PMG Research Board of Directors,” states Charles Hauser. “I look forward to the opportunity to continue to support PMG’s vision and drive for innovation within the clinical trials industry.” From 1980 to 2006, Mr. Hauser was the President and co-founder of Piedmont Medical Research Associates, now PMG Research. He has served on numerous corporate and community Boards, including the State Health Coordinating Council and the North Carolina Medical Care Commission.

John Vann has extensive experience in the clinical research industry, having co-founded Clinical Trial Management Services (CTMS) followed by several years in corporate development with a leading UK-based CRO. “I look forward to participating on the Board of PMG Research. PMG has a reputation for quality and experience, with a strong focus on patient engagement and strategic development that will help define the new landscape in clinical research,” explains Mr. Vann.

“We are grateful for the participation of Mr. Hauser and Mr. Vann on our Board of Directors. They bring an immense breadth of experience and insight, and their guidance will prove valuable as PMG continues to find innovative ways to partner with healthcare, pharma, and CROs to achieve our mission: bringing clinical research to as many lives as possible,” states Jennifer Byrne.

About PMG Research, Inc.
PMG Research, Inc. is an integrated network of clinical research facilities with hub sites located in Cary, Charlotte, Hickory, Raleigh, Salisbury, Wilmington, and Winston-Salem, NC; Charleston, SC; and Bristol and Knoxville, TN. PMG has conducted 7,100 research studies for hundreds of pharmaceutical sponsors and CROs since 1979. We have extensive experience conducting all phases of trials across a comprehensive list of conditions. Our mission is to bring clinical research to as many lives as possible while delivering unparalleled service and exceptional value to our clinical trial partners and stakeholders. To learn more, visit http://www.pmg-research.com.


Contact

Follow us on: Contact's Facebook Contact's Twitter Contact's LinkedIn